Phone coaching to help teens stay on leukemia medicine
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a mobile (phone) health program to help adolescents and young adults with leukemia take their oral chemotherapy medicine consistently. It may help if staying on daily pills is hard during the maintenance phase of treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 29 years old
- You have been diagnosed with acute lymphoblastic leukemia (ALL) or lymphoma
- Your cancer treatment is in the maintenance phase, and you have at least 1 month left
- You are taking the oral chemotherapy pill 6-mercaptopurine (6MP)
- You and your study caregiver (if you have one) can read and speak English
- If you are under 18, your caregiver must be part of the consent process
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether text message reminders can help patients stick to their daily oral chemotherapy schedule during the maintenance phase of ALL treatment. Participants receive friendly text reminders and can ask questions, aiming to make managing treatment easier.
This study tests a support program that helps parents give their child's daily leukemia medicine (6-MP) on schedule and overcome any barriers. It aims to make it easier for families to stick with treatment.
This trial is for children newly diagnosed with acute lymphoblastic leukemia (ALL). It tests whether checking medicine levels in the blood can help optimize ongoing treatment (maintenance) and potentially keep the cancer under control.
This trial tests a standard chemotherapy regimen for people aged 18 to 50 with a type of leukemia called Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). It aims to see how well the treatment works for this age group.
This study tests a social media-based program to help teens and young adults with acute lymphoblastic leukemia (ALL) take their daily chemotherapy pill (6-MP) more regularly. It may help you if you've missed a dose recently or find it hard to stick to your medication schedule.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
Hear when a new Acute Lymphoblastic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.